Rabbit Anti-Phospho-CSF1R (Tyr723) Recombinant Antibody (49C10) (CBMAB-CP0381-LY)

Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Phosphorylates PIK3R1, PLCG2, GRB2, SLA2 and CBL. Activation of PLCG2 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, that then lead to the activation of protein kinase C family members, especially PRKCD. Phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leads to activation of the AKT1 signaling pathway. Activated CSF1R also mediates activation of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1, and of the SRC family kinases SRC, FYN and YES1. Activated CSF1R transmits signals both via proteins that directly interact with phosphorylated tyrosine residues in its intracellular domain, or via adapter proteins, such as GRB2. Promotes activation of STAT family members STAT3, STAT5A and/or STAT5B. Promotes tyrosine phosphorylation of SHC1 and INPP5D/SHIP-1. Receptor signaling is down-regulated by protein phosphatases, such as INPP5D/SHIP-1, that dephosphorylate the receptor and its downstream effectors, and by rapid internalization of the activated receptor. In the central nervous system, may play a role in the development of microglia macrophages (PubMed:30982608).
Cell-cell junction maintenance Source: UniProtKB
Cell population proliferation Source: UniProtKB
Cellular response to cytokine stimulus Source: UniProtKB
Cellular response to macrophage colony-stimulating factor stimulus Source: UniProtKB
Cytokine-mediated signaling pathway Source: UniProtKB
Forebrain neuron differentiation Source: Ensembl
Hematopoietic progenitor cell differentiation Source: GO_Central
Hemopoiesis Source: UniProtKB
Inflammatory response Source: UniProtKB
Innate immune response Source: UniProtKB-KW
Macrophage colony-stimulating factor signaling pathway Source: BHF-UCL
Macrophage differentiation Source: UniProtKB
Mammary gland duct morphogenesis Source: UniProtKB
Microglial cell proliferation Source: Ensembl
Monocyte differentiation Source: UniProtKB
Multicellular organism development Source: GO_Central
Negative regulation of apoptotic process Source: Ensembl
Negative regulation of cell population proliferation Source: Ensembl
Olfactory bulb development Source: Ensembl
Osteoclast differentiation Source: UniProtKB
Peptidyl-tyrosine phosphorylation Source: UniProtKB
Phosphatidylinositol-mediated signaling Source: UniProtKB
Phosphatidylinositol metabolic process Source: UniProtKB
Positive regulation by host of viral process Source: Ensembl
Positive regulation of cell migration Source: UniProtKB
Positive regulation of cell motility Source: UniProtKB
Positive regulation of cell population proliferation Source: UniProtKB
Positive regulation of chemokine production Source: UniProtKB
Positive regulation of ERK1 and ERK2 cascade Source: UniProtKB
Positive regulation of kinase activity Source: GO_Central
Positive regulation of macrophage chemotaxis Source: ARUK-UCL
Positive regulation of macrophage proliferation Source: ARUK-UCL
Positive regulation of protein phosphorylation Source: UniProtKB
Positive regulation of protein serine/threonine kinase activity Source: UniProtKB
Positive regulation of protein tyrosine kinase activity Source: UniProtKB
Positive regulation of tyrosine phosphorylation of STAT protein Source: UniProtKB
Protein autophosphorylation Source: UniProtKB
Regulation of actin cytoskeleton reorganization Source: UniProtKB
Regulation of bone resorption Source: UniProtKB
Regulation of cell shape Source: UniProtKB
Regulation of transcription initiation from RNA polymerase II promoter Source: Reactome
Response to ischemia Source: ARUK-UCL
Ruffle organization Source: UniProtKB
Signal transduction Source: ProtInc
Transmembrane receptor protein tyrosine kinase signaling pathway Source: UniProtKB
Aberrant expression of CSF1 or CSF1R may play a role in inflammatory diseases, such as rheumatoid arthritis, glomerulonephritis, atherosclerosis, and allograft rejection.
Leukoencephalopathy, diffuse hereditary, with spheroids (HDLS):
An autosomal dominant adult-onset rapidly progressive neurodegenerative disorder characterized by variable behavioral, cognitive, and motor changes. Patients often die of dementia within 6 years of onset. Brain imaging shows patchy abnormalities in the cerebral white matter, predominantly affecting the frontal and parietal lobes.
Brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS):
An autosomal recessive disease with variable manifestations. Main features are brain malformations with calcifying leukoencephalopathy, progressive neurodegeneration, and bone sclerotic features. The age at onset ranges from infancy to early adulthood. Neurologic features include loss of previous motor and language skills, cognitive impairment, spasticity, and focal seizures. Brain imaging shows periventricular white matter abnormalities and calcifications, large cisterna magna or Dandy-Walker malformation, and sometimes agenesis of the corpus callosum.
Helical: 518-538
Cytoplasmic: 539-972
Ubiquitinated. Becomes rapidly polyubiquitinated after autophosphorylation, leading to its degradation.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
